The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

Author: Sidhu J.S.   Cowan D.   Kaski J.-C.  

Publisher: Elsevier

ISSN: 0735-1097

Source: Journal of the American College of Cardiology, Vol.42, Iss.10, 2003-11, pp. : 1757-1763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content